Essai clinique

VR Therapies for IBD

NCT : NCT07590518 · NOT_YET_RECRUITING

ID NCTNCT07590518

StatutNOT_YET_RECRUITING

SponsorBrennan Spiegel (OTHER)

First posted2026-05-15

Last updated2026-05-15

Résumé succinct

Through a pilot randomized controlled trial (RCT), the aim is to test the clinical impact and feasibility of a AI-enhanced Virtual Reality (VR) Cognitive Behavioral therapy (CBT) program versus distraction VR among patients with inflammatory bowel disease (IBD) and anxiety. It is hypothesized that using VR/AI CBT may reduce anxiety and IBD symptoms, leading to improved overall physical, psychological, and social functioning when compared to distraction VR.

Source officielle

Voir sur ClinicalTrials.gov →

Données issues de l’API ClinicalTrials.gov. Pour connaître le statut le plus récent, consultez la fiche officielle.